Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENCORAFENIB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

50.9%
Female
49.1%
Male

Age Information

The average age of patients reporting adverse events with ENCORAFENIB is 64.4 years.

Geographic Distribution

The majority of adverse event reports for ENCORAFENIB originate from US.

Report Summary & Outcomes

8,554
Total Reports
8,554
As Primary/Secondary Suspect
1,397
Deaths Reported
2,334
Hospitalizations
214
Life-Threatening
63
Disabilities

Reporting Timeline

First adverse event report: 2011. Most recent report: 20250920. View full timeline →

More About ENCORAFENIB

ENCORAFENIB Full Profile Reports by Year Drug Interactions